H
Harvard Bioscience D
D
HBIO
5.67000
USD
-0.01
(-0.09%)
Market Closed
Volume
412
EPS
0
Div Yield
-
P/E
-3
Market Cap
25,572,732
Title: Harvard Bioscience Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction andin vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.